This website uses cookies to ensure you get the best experience on the website.If you continue to browse, then you agree to our Cookie Policy and Privacy Policy.
Prolacta Bioscience is transforming care for vulnerable babies by unlocking the power of human milk. Their clinically proven products improve health and reduce complications for critically ill infants worldwide. Prolacta operates the world's first pharmaceutical-grade human milk processing facilities and utilizes vat pasteurization and a patented manufacturing process to retain the highest levels of essential bioactive components while ensuring pathogen inactivation. With over 20 clinical studies supporting their products, Prolacta is setting the bar for state-of-the-art care. Visit their website to learn more about their quality and safety standards, as well as the latest research and how to bring their products into your NICU.
Research, Improvement, and Follow Through: Integrating evidence into practice with the exclusive human milk diet (EHMD). This webinar will cover the interpretation of recent clinical and basic science research on EHMD, how EHMD implementation and practice may differ from previous cow-milk based practices, utilization of published evidence to generate process-focused QI projects for NICUs, and real-world data and lessons from NICUs using EHMD.